XML 23 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies (Details Narrative)
1 Months Ended 9 Months Ended
Apr. 28, 2019
USD ($)
Mar. 26, 2019
USD ($)
Feb. 28, 2019
USD ($)
May 24, 2018
shares
Apr. 10, 2018
USD ($)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
ILS (₪)
Jun. 08, 2017
USD ($)
Sep. 30, 2018
USD ($)
Jul. 31, 2018
USD ($)
Apr. 30, 2018
USD ($)
Jun. 30, 2012
Sep. 30, 2019
USD ($)
Purchase Price of Plaintiffs     $ 3,375,000                    
Monthly Consultation Fee | ₪             ₪ 40,000            
Alliance Investment Management, Ltd. [Member]                          
Litigation settlement $ 480,000                        
CardioSert Ltd [Member]                          
Initial Payment         $ 250,000 $ 50,000              
Number of Common Shares Acquired | shares       6,738 6,738                
Number of Common Shares Acquired, Value         $ 74,000                
Buy Back Amount Per Patent | $ / shares           $ 1.00              
CardioSert Ltd [Member] | Before Reverse Split [Member]                          
Number of Common Shares Acquired | shares       100,000 100,000                
Bonding Agent [Member]                          
Purchase Price of Plaintiffs   $ 4,200,000                      
Additional Expenses Respect to Interest from the Judgement Date   $ 178,000                      
Securities Purchase Agreement [Member]                          
Purchase Price of Plaintiffs               $ 3,375,000          
Loss Contingency, Damages Sought               $ 1,000,000          
Minimum [Member] | Alliance Investment Management, Ltd. [Member]                          
Beneficial Ownership Percentage 10.00%                        
Minimum [Member] | CardioSert Ltd [Member]                          
Investments           $ 2,000,000              
Minimum [Member] | Technion Research and Development Foundation Limited [Member]                          
Royalties Payable as Percentage of Future Sales                       1.50%  
Maximum [Member] | Technion Research and Development Foundation Limited [Member]                          
Royalties Payable as Percentage of Future Sales                       3.00%  
Second Phase [Member] | Contract Research Agreements [Member]                          
Contract Expected Costs                 $ 248,000   $ 130,000    
Phase 2.1 [Member] | Contract Research Agreements [Member]                          
Contract Expected Costs                   $ 213,000      
Israeli Innovation Authority [Member] | 2013 Through September 30, 2019 [Member]                          
Total Grants Obtained                         $ 1,500,000
Israeli Innovation Authority [Member] | 2013 Through September 30, 2019 [Member] | Minimum [Member]                          
Royalties Payable as Percentage of Future Sales                         3.00%
Israeli Innovation Authority [Member] | 2013 Through September 30, 2019 [Member] | Maximum [Member]                          
Royalties Payable as Percentage of Future Sales                         3.50%